Patent Assignment
Reel/Frame 060249/0066
Change of Address
Recorded: 2022-06-01
Pages: 2
Assignor
HEPTARES THERAPEUTICS LIMITED
Executed: 2018-07-25
Assignee
HEPTARES THERAPEUTICS LIMITED
GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, CAMBRIDGESHIRE, CB21 6DG, UNITED KINGDOM
Covered Properties
(3)
4-(3-Cyanophenyl)-6-Pyridinylpyrimidine MGLU5 Modulators
Methods of Treatment Using 4-(3-Cyanophenyl)-6-Pyridinylpyrimidine MGLU5 Modulators
Methods of Treatment Using 4-(3-Cyanophenyl)-6-Pyridinylpyrimidine MGLU5 Modulators
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 29, 2020
From: CHRISTOPHER, JOHN ANDREW; CONGREVE, MILES STUART; AVES, SARAH JOANNE; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 052526/0519 →
Assignment of Assignor's Interest
May 18, 2021
From: CHRISTOPHER, JOHN ANDREW; CONGREVE, MILES STUART; AVES, SARAH JOANNE; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 056280/0288 →
Assignment of Assignor's Interest
Apr 8, 2022
From: CHRISTOPHER, JOHN ANDREW; CONGREVE, MILES STUART; AVES, SARAH JOANNE; TEHAN, BENJAMIN GERALD
To: HEPTARES THERAPEUTICS LIMITED
Reel/Frame 059550/0826 →
Change of Name
Aug 8, 2024
From: HEPTARES THERAPEUTICS LIMITED
To: NXERA PHARMA UK LIMITED
Reel/Frame 068230/0394 →